.elisabeth Chartier-Garcia

Mrs. .elisabeth Chartier-Garcia


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AGAlexis Gonneaud
Alexis Gonneaud
FFFatima-Zohra Fakhir
Fatima-Zohra Fakhir
ELEmeline Landas
Emeline Landas
ETEnora Le Tallec
Enora Le Tallec
.C.elisabeth Chartier-Garcia
.elisabeth Chartier-Garcia
CMChristel Marquette
Christel Marquette
Bcl-xL, a member of the Bcl-2 family, is a pro-survival protein involved in apoptosis regulation. We have previously reported the ability of Bcl-xL to form various types of fibers, from native to amyloid conformations. Here, we have mimicked the effect of apoptosis-induced caspase activity on Bcl-xL by limited proteolysis using trypsin. We show that cleaved Bcl-xL (ΔN-Bcl-xL) forms fibers that exhibit the features of amyloid structures (BclxLcf37). Moreover, three monoclonal antibodies (mAbs), produced by mouse immunization and directed against ΔN-Bcl-xL or Bcl-xL fibers, were selected and characterized. Our results show that these mAbs specifically target ΔN-Bcl-xL in amyloid fibers in vitro. Upon metal-stress-induced apoptosis, these mAbs are able to detect the presence of Bcl-xL in amyloid aggregates in neuroblastoma SH-SY5Y cell lines. In conclusion, these specific mAbs directed against amyloidogenic conformations of Bcl-xL constitute promising tools for studying, in vitro and in cellulo, the contribution of Bcl-xL in apoptosis. These mAbs may further help in developing new diagnostics and therapies, considering Bcl-xL as a strategic target for treating brain lesions relevant to stroke and neurodegenerative diseases.

8 May 2026 in Nanomaterials
Verified
Journal Article
Open access
PDF file
KPKlaudia Pepłowska
Klaudia Pepłowska
JHJaana Huotari
Jaana Huotari
KCKinga Czechowska
Kinga Czechowska
VMVitipon Marianne
Vitipon Marianne
VCVéronique Collin-Faure
Véronique Collin-Faure
TRThierry Rabilloud
Thierry Rabilloud
Copper has been used as a biocide for more than one century, in various applications. However, as a biocide, copper, both metallic, as a salt or as copper oxide particles, is toxic not only to its intended targets, mainly bacteria and fungi, but also to all living cells. Because of this toxicity, it is desirable to use forms of copper that maximize the required biocidal activity while minimizing the amount of copper that will be released in the environment. Copper oxide nanoparticles are a good compromise for all these requirements. The high surface ratio allows for good reactivity and thus good biocidal activity, while the small amount of copper present in nanoparticles compared to microparticles allows for a limited environmental release. However, plain copper oxide nanoparticles still show significant cytotoxicity, thereby limiting their use. We, therefore, investigated if doping copper oxide nanoparticles with other metal oxide nanoparticles, namely zinc oxide or titanium dioxide, would alter the functional features of the resulting nanoparticles, hopefully increasing the biocidal activity vs. toxicity balance. We investigated biocidal activity by stringent tests using both Staphylococcus aureus and Escherichia coli as target bacteria. In addition, we investigated toxicity on mammalian macrophages or keratinocytes cell lines, as well as on an insect hemocyte cell line. Doping with zinc oxide decreased the biocidal activity, while increasing toxicity, which was the opposite of our expectations. Doping with titanium dioxide decreased the biocidal activity, but also markedly decreased cytotoxicity, which is an interesting avenue to follow. In addition, we also checked that beyond toxicity, the copper oxide-based nanoparticles did not induce an inflammatory reaction, making them safer to use.